Takeda Pharmaceutical Mergers and Acquisitions Summary

Healthcare Services Company

Takeda Pharmaceutical has acquired 17 companies, including 5 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 6 assets.

Takeda Pharmaceutical’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2015, when it sold Takeda Pharmaceutical Company - Core Respiratory Business to AstraZeneca for $575M. Takeda Pharmaceutical has acquired in 6 different US states, and 5 countries. The Company’s most targeted sectors include life science (93%) and healthcare services (8%).

Join Mergr and gain access to Takeda Pharmaceutical’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.

M&A Summary

  • M&A Total Activity19
    • M&A Buy Activity13
    • M&A Sell Activity6
  • Total Sectors Invested 2
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 13
  • M&A Advisors 7

Takeda Pharmaceutical Co.,Ltd.

1-1, Nihonbashi-Honcho 2-chome Chuo-ku,
Osaka, 103-8668
Japan,
+81 3 3278 2306
www.takeda.com

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc.The Company operates in three business segments,Ethical, Healthcare and others. Takeda Pharmaceutical Company was founded in 1781 and is based in Tokyo, Japan.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.8/yr) # 9 1 2 - 1 - 13
vol $20.0B $5.2B $67.7B $93.0B
Sell (1.0/yr) # 1 - - 2 3 - 6
vol $575M $200M $842M $1.6B
  19

Most Recent M&A

Company Date Value Type
Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets 2020-11-30 278M USD Divestiture
Osaka, Japan
Takeda Pharmaceutical Co.,Ltd. - TachoSil 2020-09-16 564M USD Divestiture
Osaka, Japan
Takeda Pharmaceutical Co.,Ltd. - Buccolam 2020-09-14 - Divestiture
Osaka, Japan
PvP Biologics, Inc. 2020-02-26 - Add-on Acquisition
San Diego, California · www.pvpbio.com
Takeda Pharmaceutical Co.,Ltd. - Primary Care Portfolio 2019-10-15 200M USD Divestiture
Osaka, Japan
Xiidra 2019-05-09 - Divestiture
Dublin, Ireland · www.xiidra.com
TiGenix N.V. 2018-07-31 - Add-on Acquisition
Leuven, Belgium · www.tigenix.com
Shire plc 2018-05-08 67.7B GBP Add-on Acquisition
Dublin, Ireland · www.shire.com
Ariad Pharmaceuticals, Inc. 2017-01-09 5.2B USD Add-on Acquisition
Cambridge, Massachusetts · www.ariad.com
Baxalta - Biologics Manufacturing Facility 2016-01-05 - Divestiture
Brooklyn Park, Minnesota
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Takeda Pharmaceuticals U.S.A., Inc.    - Gaido Health 2020-04-16 2
Deerfield, Illinois · www.takeda.us Los Angeles, California
Takeda Pharmaceuticals U.S.A., Inc.    - URL Pharma, Inc. 2012-12-17 1
Deerfield, Illinois · www.takeda.us Philadelphia, Pennsylvania · www.urlpharma.com
Millennium Pharmaceuticals, Inc.    - LeukoSite, Inc. 1999-12-22 1
Cambridge, Massachusetts · www.millennium.com Cambridge, Massachusetts

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 12 (92%) 92.9B (100%) 3 (50%) 853M (53%)
Medical Products - - 3 (50%) 764M (47%)
Healthcare Services 1 (8%) 35M (< 1%) - -
Total 13 $93.0B 6 $1.6B

By Geo

State/Country Buy Value Sell Value
United States 9 14.4B - -
  California 3 190M - -
  Massachusetts 2 14.0B - -
  Montana 1 60M - -
  Minnesota 1 - - -
  Florida 1 140M - -
  Colorado 1 35M - -
Japan - - 5 1.6B
Ireland 1 67.7B 1 -
Belgium 1 - - -
Switzerland 1 10.8B - -
United Kingdom 1 - - -
Domestic - - 5 (83%) 1.6B (100%)
Cross-border 13 (100%) 93.0B (100%) 1 (17%) -
Total 13 $93.0B 6 $1.6B

Top M&A Advisors

Financial Deals
Deutsche Bank Corporate & Investment Banking
1
Evercore Group LLC
1
UBS Investment Bank
1
Legal Deals
Cleary Gottlieb Steen & Hamilton LLP
1
Edwards Wildman Palmer LLP
1
Polsinelli PC
1

Deal Values

buy # Total
> $1B 4 $92.6B
$100M to $1B 2 $330M
< $100M 2 $95M
TOTAL $93.0B
Largest Shire plc
$67.7B (2018-05-08)
sell # Total
$100M to $1B 4 $1.6B
TOTAL $1.6B
Largest Takeda Pharmaceutical Company - Core Respiratory Business
$575M (2015-12-16)

M&A Connections

Deals
Acquired from
Investor(s)
15%
2 (15%)
Strategic(s)
8%
1 (8%)
Divested to
Strategic(s)
100%
6 (100%)

 Subscribe to unlock this and 161,248
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 150K M&A Transactions
  • 157K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 48K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.